EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms

Dung T Tran iD, Yulu Chen, Yi Zheng, Julian Hecker, Daniel B Hawcutt, Munir Pirmohamed, Jessica Lasky-Su, Ann C Wu, Kelan G Tantisira, Michael J McGeachie, Scott T Weiss, Amber Dahlin

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Dung T Tran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Asthma, Metabolomics, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma is routinely treated with inhaled corticosteroids (ICS). Asthma patients on ICS are at increased risk of adrenal suppression, a potentially serious effect of long‐term glucocorticoid exposure; however, this relationship is poorly understood. Therefore, this study aims to identify metabolite biomarkers related to adrenal suppression in asthma patients taking ICS.

Methods

A total of 571 urine metabolites from 200 children with asthma on ICS in the Pharmacogenetics of Adrenal Suppression with Inhaled Steroids (PASS) cohort were profiled. Samples were grouped by peak plasma cortisol measurement as adrenal sufficient (>350 nmol/L) or insufficient (≤350 nmol/L) (outcome). Regression and discriminant‐based statistical models combined with network analyses were utilized to assess relationships between metabolites and the outcome. Finally, prioritized metabolites were validated using data from an ancillary study of the Childhood Asthma Management (CAMP) cohort with similar characteristics to PASS.

Results

Ninety metabolites were significantly associated with adrenal suppression, of which 57 also could discriminate adrenal status. While 26 metabolites (primarily steroids) were present at lower levels in the adrenal insufficient patients, 14 were significantly elevated in this group; the top metabolite, mannitol/sorbitol, was previously associated with asthma exacerbations. Network analyses identified unique clusters of metabolites related to steroids, fatty acid oxidation, and nucleoside metabolism, respectively. Four metabolites including urocanic acid, acetylcarnitine, uracil, and sorbitol were validated in CAMP cohort for adrenal suppression.

Conclusions

Urinary metabolites differ among asthma patients on ICS, by adrenal status. While steroid metabolites were reduced in patients with poor adrenal function, our findings also implicate previously unreported metabolites involved in amino acid, lipid, and nucleoside metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetabolomicsAdrenal Cortex HormonesHumansChildMaleFemaleAdministration, InhalationBiomarkersAdolescentMetabolomeAdrenal InsufficiencyChild, PreschoolHydrocortisoneAdrenal GlandsCohort Studies

Stichwörter der Autor:innen

ICSadrenal functionasthmabiomarkermetabolomics

Substanzen

Adrenal Cortex HormonesBiomarkersHydrocortisone

Autor:innen und Institutionen

  • Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • University of Liverpool, Liverpool, UK.
  • Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Division of Pediatric Respiratory Medicine, University of California San Diego and Rady Children's Hospital, San Diego, California, USA.

ORCID-Profile: Dung T Tran

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Tran, D. T., Chen, Y., Zheng, Y., Hecker, J., Hawcutt, D. B., Pirmohamed, M., Lasky-Su, J., Wu, A. C., Tantisira, K. G., McGeachie, M. J., Weiss, S. T., & Dahlin, A. (2024). Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1315

Vancouver

Tran DT, Chen Y, Zheng Y, Hecker J, Hawcutt DB, Pirmohamed M, et al. Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1315

BibTeX
@article{Tran2024,
  author = {Tran, Dung T and Chen, Yulu and Zheng, Yi and Hecker, Julian and Hawcutt, Daniel B and Pirmohamed, Munir and Lasky-Su, Jessica and Wu, Ann C and Tantisira, Kelan G and McGeachie, Michael J and Weiss, Scott T and Dahlin, Amber},
  title = {Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1315}
}
Kostenlos starten →